Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
Honorine Lebraud(Advanced Systems Technology (United States)), Tom D. Heightman(AstraZeneca (Brazil))
Cited by 14
Related Papers
Visualization of Endogenous ERK1/2 in Cells with a Bioorthogonal Covalent Probe
|Bioconjugate Chemistry|2017|10